Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029
Elutia Inc. received the full $8 million escrow payment from Boston Scientific related to the sale of its BioEnvelope business, marking the final of three funding milestones in 2026. These financial achievements have positioned Elutia to be fully funded through the first year of the anticipated NXT-41x commercial launch and into 2029 without needin…